The Innovation Hub located in Songdo, Incheon will encompass a manufacturing facility and customer experience lab. Operations of the manufacturing facility are anticipated to begin in 2026, with a focus… Read More
Advances INM-901 program targeting several biological pathways associated with Alzheimer’s disease Further develops INM-089 demonstrating neuroprotection in the treatment of dry Age-related Macular Degeneration $4.6M revenues in fiscal year 2024,… Read More
McCarthy Tétrault was recognized with four awards at International Tax Review’s annual ITR Americas Tax Awards gala in New York City. The firm was named Tax Firm of the Year (Canada),… Read More
First-ever DehydraTECH-processed tirzepatide from Zepbound® to be tested in a swallowed oral format KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms… Read More
Teliso-V is an investigational antibody-drug conjugate (ADC) for patients with previously treated nonsquamous non-small cell lung cancer (NSCLC) with c-Met protein overexpression. Biologics License Application (BLA) submission for accelerated approval… Read More
